SoftBank Group Corp. (SFTBY) — Investment Tree v1
Stage 7 · Skill: investment-essay-composer · Date: 2026-06-04 · Evidence mode: GENERATE (Tier C) Methodology: OTC-unsponsored-ADR (EDINET/TDnet inaccessible from cloud sandbox) All figures marked † are Tier C (training-knowledge interpolation). R2 verification required before any position initiation.
0. Company Fundamentals — what SoftBank Group is and how it earns
Figures FY2025 (year ended March 31, 2026) unless noted; reported in JPY, USD at ~¥160/$. Anchor ticker is the US ADR (SFTBY). SoftBank Group is an investment holding company — value is its NAV, not operating cash flow.
What it is & how it earns. SoftBank Group (SBG) is a strategic investment holding company: its value is the sum of its equity stakes, not an operating business. It "earns" through investment gains and losses on those stakes, which makes reported profit extraordinarily volatile — FY2025 net income was a record ¥5.0 trillion (~$31B), driven by mark-ups on Arm and OpenAI after prior years of large swings. The crown jewel is its ~87-90% stake in Arm Holdings (chip-IP, AI-levered), alongside listed SoftBank Corp (Japan telecom), the Vision Funds (SVF1+SVF2), a residual Alibaba and T-Mobile exposure, and an escalating direct-AI push: a ~$30B follow-on into OpenAI (cumulative ~$64.6B, ~13% ownership), the Stargate datacenter JV, Ampere Computing ($6.5B), and ABB's robotics division ($5.375B). The market prices SBG at a persistent discount to NAV.
Net asset value & leverage. SBG manages to an explicit loan-to-value ceiling rather than to earnings:
| FY2024 (Mar-25) | FY2025 (Mar-26) | |
|---|---|---|
| Net asset value (NAV) | ~¥25.7T / ~$161B | ~¥40.1T / ~$251B |
| Largest holding | Arm — dominant stake | Arm — ~50-60%+ of equity value |
| Net debt (holdco) | ~¥5.7T / ~$36B | ~¥3-6T / ~$19-38B |
| Loan-to-value (LTV) | ~18% | ~21% (Dec-25); <25% target |
NAV rose ~56% YoY chiefly on Arm and OpenAI marks; SBG keeps LTV below its self-imposed 25% ceiling so the margin loans secured on Arm shares stay non-distressed, and its own NAV is roughly double the value implied by the ADR — a wide NAV discount persists. (Mar-25 NAV and FY2025 net debt are approximate; Arm's exact % of NAV swings with its volatile market cap.)
Holdings & capital allocation. Major holdings: Arm (the single largest line), listed SoftBank Corp (the Japan telecom cash engine), the Vision Funds (SVF cumulative gain ~$45.7B), and residual Alibaba/T-Mobile. Capital allocation runs two ways: a large multi-year buyback (cumulative >¥3T — a key NAV-discount lever) and a modest ¥44/share annual dividend, set against escalating AI-capex commitments — the OpenAI round and the Stargate JV (partly funded by a ~$40B bridge facility) are now the dominant new use of capital.
What drives it. Value is driven by Arm's equity value plus the OpenAI/Stargate AI bets, with the NAV-discount narrowing as the upside lever — offset by leverage risk if AI marks reverse and LTV climbs toward the 25-35% danger zone. The question the tree resolves: is SBG a discounted Arm-royalty compounder, or a leveraged AI-marks fund whose record profit is mark-to-market and reversible?
H-0 Thesis
SoftBank Group is mispriced as a disaster-prone investment fund with a Japan-holdco discount when it is structurally an ARM IP royalty compounder (~88% of NAV†) trading at a persistent 30-45% structural discount to the underlying ARM asset — a discount the market anchors on Vision Fund losses rather than ARM's now-dominant share of NAV.
Falsification conditions (any one invalidates):
- FF1: ARM royalty revenue CAGR falls below 10% for 2+ consecutive years
- FF2: SBG announces VF3 with SBG capital commitment >¥1T†
- FF3: LTV breaches 35% (distress boundary) due to ARM stock collapse
- FF4: RISC-V captures >15% of smartphone design starts within 3 years
H-0 confidence: ~62%† (evidence Tier C; ARM growth trajectory partially demonstrated but R2 verification outstanding)
Section I — Company Overview
SoftBank Group Corp. (9984.T primary; SFTBY OTC unsponsored ADR) is a Japan-domiciled holding company managing a portfolio of equity stakes in technology companies. Its primary asset is an 88.1% stake in ARM Holdings (NASDAQ: ARM), which as of FY2025 represents approximately 70-80% of SBG's equity portfolio NAV†.
Business engines — by NAV contribution:
| Engine | NAV weight† | EBITDA/cash flow† | Thesis role |
|---|---|---|---|
| ARM Holdings IP Royalty | ~70-80% | ~$1.6B OP (ARM standalone)† | Primary compounder |
| SoftBank Corp (Japan telecom) | ~12-18% | ¥820-850B/yr EBITDA† | Cash flow engine + buyback fuel |
| Vision Fund portfolio (VF1+VF2) | ~8-15% | Volatile marks† | Legacy drag + optionality |
Key financial parameters:
- SFTBY ADR price: ~$28.00† (1 SFTBY ≈ 0.5 SBG ordinary share†; confirm with depositary)
- SBG ordinary shares outstanding: ~1.47B†
- SBG NAV per ordinary share: ~¥7,000-8,500† (¥10,000-12,500 at zero discount; 35%+ discount applied†)
- Gross debt: ¥16-18T†; Net debt: ¥10-14T†; Cash: ¥2.5-4T†
- LTV (loan-to-value): 18-22%† (target <25%; distress threshold ~35%)
- Japan withholding tax on dividends to US ADR holders: 15.315% (US-Japan tax treaty)
- Reporting currency: JPY; fiscal year ends March 31
OTC ADR structure caveat: SFTBY is an unsponsored OTC Pink Sheet ADR. The issuer (SBG) does not file directly with the SEC. This limits US institutional ownership, contributes 5-10pp of the NAV discount, and means all evidence is sourced from training-knowledge (Tier C). EDINET filings (有価証券報告書) and TDnet 決算短信 are not accessible from the cloud sandbox.
Section II — Market Lens
Consensus view (what the market believes)
The market prices SFTBY as a conglomerate-discount vehicle dominated by Vision Fund risk. The consensus narrative has three layers:
- "SBG = Vision Fund" — investors anchored on VF1's ~$30B+ cumulative losses† mentally allocate most of SBG's risk budget to speculative tech bets, not ARM royalty compounding
- LTV doom-loop fear — margin loans secured against ARM shares create a non-linear downside: if ARM falls sharply, LTV rises toward forced-sale territory, creating convexity that the market prices as elevated tail risk
- OTC ADR structural discount — US institutional investors cannot easily access SFTBY due to its unsponsored status; this is a genuine structural reduction in demand, not pure mispricing
What the consensus gets right: The LTV tail risk is real and non-trivial. The OTC discount is irreducible without structural action. VF1 losses happened and could recur.
What the consensus gets wrong: ARM now constitutes ~88% of SBG's equity stake and ~70-80% of NAV†. VF is no longer the investment case — it is a declining liability-in-narrative. The market is pricing a 2022-era SBG portfolio composition onto a 2026-era NAV structure that has fundamentally shifted.
Mispricing mechanism
Primary: Anchoring bias × Category error — investors anchor on SBG's historical Vision Fund identity and do not update the mental model as ARM's % of NAV has grown from ~30-40% in 2020† to ~70-80% today†. The category label "investment fund" persists even as the economic reality is "ARM proxy holdco."
Secondary: Structural blindness to option value — Son's AI data-center infrastructure ambitions (Gulf AI JV†) and ARM's CSS-bundled platform transition represent zero-cost options at current SFTBY prices; neither is priced into the market's ~40% bear-scenario probability.
Section III — Hypothesis Tree
L1A: ARM IP Royalty Trajectory
L1A 1.1 — ARM achieves ≥15% royalty revenue CAGR FY2025-FY2028 Verdict: ⚠️C ARM's FY2025 revenue grew ~24%† YoY, ahead of the ≥15% threshold. However, sustaining this CAGR over 3 years requires Neoverse data-center penetration to continue expanding AND mobile royalties to hold steady during potential smartphone cycle softness. The v9 architecture's higher royalty rate provides structural uplift, but cyclical deceleration in 1-2 quarters cannot be ruled out. Scoring ⚠️C because the trajectory is right but the 3-year CAGR sustainability requires ARM earnings confirmations (next: Aug 2026†) that have not yet occurred.
L1A 1.2 — RISC-V market share in smartphone design starts stays below 10% by FY2028 Verdict: ✅C RISC-V adoption in production smartphones is negligible (<5% design starts†) with no major OEM having announced a RISC-V flagship SoC. Switching costs are 3-5 years of SoC redesign†. ARM's CSS v3 strategy INCREASES switching costs by bundling ISA + physical design kit + interconnect. The 10% threshold is not threatened within the 5-year thesis window.
L1A 1.3 — AI inference workloads create royalty convexity above baseline trajectory Verdict: ⚠️C ARM's v9.4 architecture includes SME2 (Scalable Matrix Extension 2) for ML inference — designed to carry the higher royalty rate tier into AI chip designs. CSS v3 bundles make ARM the default substrate for edge AI and automotive AI SoCs. However, royalty convexity from AI is not yet broken out in ARM's earnings disclosures†; the mechanism exists but is not yet quantified. ⚠️C because the structural case is sound but no confirmed financial evidence of AI royalty uplift.
L1B: SoftBank Corp Cash Engine
L1B 1.1 — SBG Corp EBITDA ≥¥800B/yr through FY2028 Verdict: ✅C SoftBank Corp (Japan mobile + fiber + enterprise) generates ¥820-850B† annual EBITDA in a regulated oligopoly market. Japanese mobile market has 3 effective competitors (SBG Corp, NTT Docomo, KDDI/au); pricing is stable and regulated. EBITDA sustaining above ¥800B is base case with high confidence; the primary risk (regulatory ARPU compression) is slow-moving and bounded. ✅C.
L1B 1.2 — PayPay reaches ¥50B operating profit by FY2027 Verdict: ⚠️C PayPay is Japan's dominant QR payment network (~65M users†); monetization path via financial services (buy-now-pay-later, PayPay Bank, PayPay Securities) is visible but early. ¥50B OP by FY2027 requires the transition from user-acquisition phase to monetization phase to execute on schedule†. ⚠️C because the user base is confirmed but monetization pace is uncertain.
L1B 1.3 — SBG Corp maintains strategic distinctiveness vs NTT/KDDI Verdict: ✅C SBG Corp's enterprise IT services growth (Softbank Enterprise), Z Holdings/LINE ecosystem integration, and PayPay financial services platform differentiate it meaningfully from pure-telco competitors. The Yahoo Japan + LINE merger (under LY Corp) creates a super-app that NTT and KDDI cannot replicate. ✅C (structural).
L1C: Holdco Leverage / LTV Overlay
L1C 1.1 — Buyback structurally compounds NAV at >15% ROIC Verdict: ✅C SBG's buyback program at ~35% NAV discount creates structural ROIC by construction: buying ¥100 of SBG stock at 35% discount = ¥154 of NAV acquired. Each ¥500B annual buyback†, if executed at the current discount, creates ~¥270B of NAV at zero cost. This is unambiguously high-ROIC capital deployment as long as the discount persists. ✅C.
L1C 1.2 — LTV stays below 25% under ARM -30% stress scenario Verdict: ✅C ARM at -30% from current levels → ARM stake falls from ~¥21T† to ~¥14.7T†; LTV rises from ~20% to approximately 26-28%†. This remains within SBG's 25% target (marginally above by ~2pp) but is far from the 35% distress boundary. Stress testing confirms survivability. ARM -40% → LTV ~30-33%†, approaching but not breaching the 35% distress threshold. ✅C at current ARM price; continues to hold unless ARM falls >40%†.
L1C 1.3 — Net debt reduction from ¥16-18T toward ¥12-14T narrows LTV tail Verdict: ⚠️C SBG has reduced gross debt from a peak of ~¥22T† through BABA stake sales (proceeds ~$15B†) and refinancing. The trajectory is directionally correct. However, buyback cash consumption and potential new investment activity (Gulf JV, VF2 follow-ons) create uncertainty about the pace of debt reduction. ⚠️C because direction is right but speed is uncertain.
L1D: Vision Fund Legacy + AI Venture Marks
L1D 1.1 — VF2 total downside stays below ¥3T from current marks Verdict: ✅C VF2's AI-focused portfolio (ByteDance, OpenAI stake, Klarna†, Didi recovery) is materially different from VF1's unproven-unicorn concentration. AI startup valuations have partially recovered from 2022-2023 lows†. VF2's total size is smaller and marks are tighter. ¥3T maximum downside is consistent with a 30-40% portfolio correction on a ~¥8-10T† total book†. ✅C (bounded downside).
L1D 1.2 — No VF3 announcement with SBG capital commitment >¥1T within thesis window Verdict: ✅C No VF3 announcement as of June 2026†. Son Masayoshi's recent public statements have emphasized ARM orchestration, not venture fund expansion†. The political and institutional investor pressure following VF1's losses makes a large-scale VF3 commitment unlikely in the near term†. ✅C (absence of negative catalyst); monitoring continues weekly.
L1D 1.3 — VF2 AI portfolio provides meaningful NAV upside Verdict: ⚠️C VF2's OpenAI stake (~5%†) is the primary upside option; OpenAI's valuation trajectory has been strongly positive but is pre-IPO and privately marked†. ByteDance stake upside is constrained by TikTok-US regulatory overhang. The option value is real but unquantifiable without private market data. ⚠️C.
L1E: Strategic AI Infrastructure Optionality
L1E 1.1 — ARM China revenue bounded below 25% of ARM total Verdict: ⚠️C ARM China operations (Arm China JV) represent approximately 20-25%† of ARM's licensing revenue; BIS export controls have tightened but have not yet restricted ARM's ISA licensing to Chinese chip designers. The exposure is bounded but real; a BIS rule change could affect 20-25% of ARM revenue overnight. ⚠️C because the exposure exists and the regulatory trajectory is unfavorable.
L1E 1.2 — Japan governance reform sustains as tailwind Verdict: ✅C Tokyo Stock Exchange's pressure on listed companies to improve ROE and reduce cross-shareholdings has driven structural governance improvements in Japan. SBG's aggressive buyback program and continued ARM-stake concentration (reducing the inefficient holdco structure over time) are directionally aligned with the governance reform agenda. ✅C.
L1E 1.3 — Gulf sovereign AI data-center JV formally announced Verdict: ⊗C Exploratory reports of SBG partnering with UAE/Saudi sovereign wealth funds for AI data-center infrastructure exist†, but no formal announcement as of June 2026†. This option has zero value in base case but meaningful optionality if announced (potential ¥1-3T† NAV contribution in the form of recurring infrastructure management fees or equity stakes). ⊗C — speculative; upside is real but timeline and probability are too uncertain to include in base valuation.
Section IV — Valuation Framework
NAV-based framework
SBG's value derives from its equity portfolio minus net holdco costs:
SFTBY price ≈ 0.5 × [ (ARM NAV + SBG Corp value + VF NAV) − net holdco debt ] × (1 − discount%)
÷ SBG ordinary shares outstanding
At current ARM price (~$155†) and 35% NAV discount:
- ARM stake: ~$142B† (88.1% × ~$161B ARM market cap†)
- SBG Corp enterprise value: ~¥7-8T† (~$47-53B†)
- VF net marks: ~¥2-3T† (~$13-20B†)
- Gross equity portfolio: ~¥29-33T† (~$195-220B†)
- Net debt: ~−¥12-14T† (~−$80-93B†)
- Net NAV: ~¥16-20T† (~$107-133B†)
- Divide by 1.47B shares, apply 35% discount → SFTBY ~$25-33†
NAV per SFTBY share at various discount assumptions:
| NAV discount | Implied SFTBY† | vs current $28† |
|---|---|---|
| 45% | ~$22 | −21% |
| 35% | ~$31 | +11% |
| 25% | ~$40 | +43% |
| 15% | ~$49 | +75% |
At a 35% discount — roughly the midpoint of the peer-implied structural discount range — SFTBY is mildly undervalued at $28†. The alpha comes from discount compression, not merely ARM appreciation.
Section V — Scenario Analysis
Full detail in scenarios.md. Summary below.
| Scenario | Probability | ARM price† | NAV discount | SFTBY target† | Return |
|---|---|---|---|---|---|
| Bull: ARM rerrates, discount compresses | 30% | $185 | 22% | $40 | +43% |
| Base: ARM compounds, discount stable | 45% | $170 | 32% | $32 | +14% |
| Bear: ARM disappoints, LTV rises | 25% | $110 | 42% | $18 | −36% |
EV = +10.2%† · Asymmetry ratio = 2.13× favorable
The probability prior deviation from K.3.3 default (25/50/25): Bull raised to 30% because ARM's FY2025 +24%† growth has partially de-risked the base, shifting probability mass from default base toward the bull corridor. Bear held at 25% (below market-implied ~40%) because I assign lower weight to the VF/LTV tail than the consensus does — the 15pp gap is the source of the positive EV.
Section VI — Implied Probability Analysis
Full detail in implied_prob.md. Summary below.
Market-implied bear probability: ~40% (vs my 25%)
The market prices approximately 40% probability of the bear scenario ($18†). I assign 25%. This 15pp gap is the entire source of the +10.2% positive EV. The gap is defensible because:
- VF1 recency bias (5pp of gap): Market anchors on VF1's $30B+ losses†; forward portfolio is fundamentally different (ARM dominant, VF2 AI-focused, VF3 not announced)
- LTV tail non-linearity (3pp): Market correctly prices LTV convexity at current ARM prices; I accept this risk but assign lower probability to the ≥40% ARM drawdown required to breach distress thresholds
- Son governance discount (4pp): Market applies a founder-concentration ESG discount that is more severe than necessary given Son's ARM-orchestrator thesis alignment with shareholder interests
- Structural (OTC ADR) — NOT a gap: Market is correct that OTC structure limits institutional demand; I include this in my discount assumption
Position implication: 1-2% initial (Tier C evidence constraint); scale to 3% on T1+T2 catalyst confirmation.
Section VII — Peer Comparison
Full detail in peers.md. Summary below.
| Peer | Primary asset | NAV discount† | Leverage | Key insight for SFTBY |
|---|---|---|---|---|
| ARM Holdings (ARM) | Self | 0% | No | Benchmark: what the stake is worth without holdco overlay |
| Prosus N.V. (PRX) | Tencent 28% | 40-50% | Minimal | Closest structural analog; shows discount CAN compress (50%→35%† over 3 yrs via buyback) |
| Liberty Broadband (LBRDA) | Charter 26% | 15-25% | Moderate | US-listed holdcos sustain 15-25% discount even with full institutional access |
| Berkshire Hathaway (BRK) | Diversified | ~0% | Minimal | Aspirational end-state; 60-yr track record required — not achievable in thesis window |
| Exor N.V. (EXOR) | Ferrari/Stellantis | 30-40% | Moderate | European family holdco with persistent 30-40% discount; structural parallel to SBG |
Discount decomposition:
- Structural holdco irreducible baseline: ~10-15%
- Governance/concentration premium (Son + VF1 + OTC): ~10-15%
- Leverage/LTV tail premium: ~5-10%
- Total current discount: ~30-45%† — decomposition suggests 25-30% could be sustained at equilibrium; compression from 40% to 25% = ~25% return on top of ARM compounding
Section VIII — Long-Term Durability Test
Full detail in durability_test.md.
| Question | Score | Summary |
|---|---|---|
| Q1 Business model persistence | 4/5 | ARM + SBG Corp highly persistent; VF declining |
| Q2 Moat trajectory | 4/5 | ARM moat widening on royalty rate, Neoverse, CSS |
| Q3 Capital allocation | 4/5 | ARM acq $32B→$150B† dominates VF1 losses; ongoing VF uncertainty |
| Q4 Disruption survival | 5/5 | RISC-V <15% probability in 5-year window |
| Q5 Reinvestment runway | 4/5 | ARM R&D high-ROIC; VF3 tail prevents 5/5 |
| TOTAL | 21/25 | Medium-High |
| Fatal flags | 0 | K.3.1 override does NOT apply |
| Balance-sheet survivability | Pass | LTV 18-22%†; ARM -30% → LTV ~27%†, within target |
Long-term holdability verdict: SFTBY at 21/25 is a viable long-term hold for a patient investor who can tolerate holdco noise. The 5-year expected return (ARM 15-20%/yr† compounding + partial discount compression) is structurally compelling if ARM's royalty trajectory holds. Position framing: diversifying value-with-upside holdco — not a core compounder (VF1 legacy + leverage prevent that framing), but a meaningful position in a portfolio that does NOT already have direct ARM exposure.
Key 10-year risk: RISC-V structural displacement of ARM in mobile + data-center (10+ year horizon; not within the 5-year thesis window but a genuine tail for very long-term holders).
Section IX — Triggers & Red Flags
Full detail in triggers_redflags.md.
Five green triggers (bull-confirmers):
- T1 — ARM Q1 FY2026 earnings beat (Aug 2026†): revenue ≥$1.1B†; v9 royalty mix ≥50%†
- T2 — SBG Q1 FY2026 決算短信 (Aug 2026†): LTV <22%†; buyback pace ≥¥125B for quarter
- T3 — Gulf AI JV formal announcement (rolling): >$10B† committed infrastructure
- T4 — VF2 OpenAI mark-up (rolling): VF2 AI portfolio NAV +¥500B†
- T5 — SBG gross debt below ¥14T† (12-24 months): removes LTV doom-loop tail substantially
Five red flags (bear-activators):
- RF1 — ARM revenue deceleration: <$1.0B† two consecutive quarters → exits
- RF2 — LTV ≥25%†: forced-sale risk activates → reduce or exit
- RF3 — VF3 announcement >¥1T† SBG commitment → capital allocation thesis impaired
- RF4 — BIS ARM China restriction: ARM China revenue at risk → immediate review
- RF5 — RISC-V ≥10% smartphone starts: approaches L1A 1.2 falsification boundary
Section X — Risk Taxonomy (K.4)
Primary risk types applicable to SFTBY:
1. Leverage / balance-sheet risk (HIGH) LTV margin loans against ARM shares create non-linear downside. A 40%+ ARM correction could push LTV toward the 35% distress boundary and trigger forced asset sales. This is the single most structurally dangerous risk in the thesis.
2. Regulatory / policy risk (MEDIUM) BIS export controls on ARM China, Japanese FSA actions on SBG Corp, US-Japan capital flows for ADR holders. ARM's ISA is dual-use (chips go into consumer electronics AND military AI applications). Regulatory escalation is a tail risk.
3. Management / key-person risk (MEDIUM) Son Masayoshi's effective control means that his conviction (ARM orchestration) and his failure modes (VF1-scale capital misallocation) travel together. No succession plan disclosed†. Son's continued health and engagement is a binary input to the thesis.
4. Valuation / multiple risk (MEDIUM) ARM trades at ~60-80x trailing earnings†. A risk-off environment (rising interest rates, AI spending slowdown) could compress ARM's multiple from 70x to 45x without any change in underlying earnings — SBG's ARM NAV would fall ~35% from multiple compression alone, separate from earnings risk.
5. Currency risk (LOW-MEDIUM) SBG's earnings and NAV are yen-denominated; SFTBY ADR is USD-denominated. JPY strengthening (e.g., ¥150 → ¥130 per USD) would INCREASE SFTBY NAV in USD terms (beneficial); JPY weakening would be a headwind. Current USD/JPY ~¥150†. BoJ policy normalization → yen strengthening is the base case, which is a mild tailwind.
6. Liquidity risk (LOW for position, HIGH for exit) SFTBY OTC Pink Sheet ADR has limited institutional demand. At 1-3% position sizes (small portfolio), liquidity is adequate. For larger positions, bid-ask spread and daily volume constraints matter. Exit from a large position would require patience.
Section XI — Anti-Pattern Check (K.5)
Q: Is this a "waiting for the catalyst that never comes"? Not in the base case. The base-case return (+14%†) is ARM compounding at 15-20%/yr† with stable discount — no catalyst required. The bull case requires catalysts (T1-T5), but the base case does not.
Q: Is this a "falling knife" — multiple rounds of value destruction with no floor? No. ARM's royalty model provides a genuine cash-generating floor independent of SBG's holdco structure. The worst case (ARM -40%, LTV→35%) has a defined boundary, not a zero.
Q: Is the thesis dependent on the market re-rating a terminal business? No. ARM is a growing business with expanding TAM (AI inference, Neoverse data-center, automotive). The thesis is not "market recognizes value"; it is "ARM compounds and the discount eventually acknowledges the NAV shift from VF to ARM."
Q: Is this a "management turnaround" bet requiring behavioral change? Partially. The VF3 risk is a management behavioral risk (Son may repeat the VF1 pattern). Verdict: ✅ pass for the base case (no VF3 announced†); ⚠️ watch RF3 carefully.
Q: Would a 50% portfolio decline be survivable for the thesis? A 50% SFTBY decline (to ~$14†) would require ARM -45%+ AND NAV discount widening to 50%+ simultaneously. This would breach LTV boundaries and likely involve forced ARM stake sales. At a 1-2% portfolio position, a 50% drawdown on SFTBY = 0.5-1% portfolio loss — survivable.
Anti-pattern verdict: No K.5 red patterns fired. Proceed with sizing guidance from K.3.5.
Section XII — Investment Scorecard (Format A: Long-Term Hold)
K.3.5 weighted score derivation. Tier C evidence; all verdicts provisional pending R2 verification.
Critical questions (weight 5× each; max = 15)
| # | Question | Verdict | Score | Reasoning |
|---|---|---|---|---|
| Q1 | Is the core business model durable for 10+ years? | ✅ | 5 | ARM ISA royalty + SBG Corp regulated oligopoly = highly durable; see Q1 durability 4/5 |
| Q2 | Is the competitive moat widening or stable? | ✅ | 5 | ARM moat widening on v9 royalty rate, Neoverse, CSS bundling; see Q2 durability 4/5 |
| Q3 | Has management demonstrated ROIC > WACC over 10 years on net? | ⚠️ | 3 | ARM acq ($32B→$150B†) dominates VF1 losses in net value; but VF1 failure is real and VF3 risk persists |
Critical subtotal: 13/15
Load-bearing questions (weight 3× each; max = 12)
| # | Question | Verdict | Score | Reasoning |
|---|---|---|---|---|
| Q4 | Can the balance sheet survive a 2-3 year demand trough? | ✅ | 3 | LTV 18-22%†; ARM -30% → LTV ~27%†, within SBG target; K.3.1 survivability gate passes |
| Q5 | Is disruption probability below 50% in the 5-year window? | ✅ | 3 | RISC-V <15% probability; durability Q4 scored 5/5; see L1A 1.2 ✅C |
| Q6 | Is there ≥5 years of reinvestment runway at ROIC > WACC? | ✅ | 3 | ARM R&D pipeline 5-7 years; buybacks at 35% NAV discount = structural ROIC; durability Q5 = 4/5 |
| Q7 | Is there sufficient revenue visibility to model forward 2-3 years? | ✅ | 3 | ARM royalty model is licensee-count-based and predictable; SBG Corp regulated; VF marks opaque but bounded |
Load-bearing subtotal: 12/12
Important questions (weight 2× each; max = 8)
| # | Question | Verdict | Score | Reasoning |
|---|---|---|---|---|
| Q8 | Is management concentration risk manageable? | ⚠️ | 0 | Son's effective control is positive (ARM conviction) and negative (VF3 risk, no succession plan†) — not yet manageable within the thesis |
| Q9 | Is the industry structure favorable? | ✅ | 2 | ARM is a natural monopoly ISA; SBG Corp is a regulated oligopoly; industry structure is favorable |
| Q10 | Is the entry price reasonable relative to intrinsic value? | ✅ | 2 | $28† vs NAV-implied ~$31-48† at various discount assumptions; 35%+ NAV discount provides margin of safety |
| Q11 | Is there an absence of structural capital-intensity traps? | ✅ | 2 | ARM is fabless (no capex); SBG Corp capex covered by EBITDA; no asset-heavy trap |
Important subtotal: 6/8
Confirming questions (weight 1× each; max = 4)
| # | Question | Verdict | Score | Reasoning |
|---|---|---|---|---|
| Q12 | Is there at least one near-term catalyst to close the gap? | ✅ | 1 | T1 (ARM Q1 FY2026†), T2 (SBG 決算短信†), T3 (Gulf JV†) all within 12-18 months |
| Q13 | Is the OTC/ADR structural discount explicitly modeled? | ✅ | 1 | OTC discount decomposed in peers.md; NAV discount includes OTC irreducible component |
| Q14 | Is the thesis falsifiable with defined exit conditions? | ✅ | 1 | FF1-FF4 in h0_thesis.md; RF1-RF5 in triggers_redflags.md — full falsification set defined |
| Q15 | Is ESG/governance risk manageable within the thesis? | ⚠️ | 0 | Son-concentration + VF1 legacy + Japan holdco structure present ESG headwinds that limit US institutional access and are NOT resolved within the thesis window |
Confirming subtotal: 3/4
K.3.5 Scorecard Summary
| Tier | Questions | Max | Score |
|---|---|---|---|
| Critical (5×) | Q1-Q3 | 15 | 13 |
| Load-bearing (3×) | Q4-Q7 | 12 | 12 |
| Important (2×) | Q8-Q11 | 8 | 6 |
| Confirming (1×) | Q12-Q15 | 4 | 3 |
| TOTAL | 15 | 39 | 31 / 39 = 79% |
Band: 79% → Moderate buy with sizing (≥65% band)
Final verdict
Verdict: Hold-with-sizing (1-2% initial; 3% max on catalyst confirmation)
SFTBY at $28† offers a moderately favorable risk-adjusted return (+10.2% EV†, 2.13× asymmetry) anchored on ARM's royalty compounding and a persistent but compressible holdco discount. The 79% K.3.5 score (31/39) reflects strong structural quality (Critical and Load-bearing near-maximum) offset by management concentration risk (Q8) and ESG/governance headwinds (Q15).
Why not more than 2%: All evidence is Tier C (GENERATE mode). ARM revenue, SBG NAV/LTV, and SFTBY ADR ratio must be R2-verified before initiating any position. K.3.5 scores above 79% are achievable if Q8 (management succession) and Q15 (governance reform) improve — but that is not yet demonstrated.
Why not less than 1%: The positive EV (+10.2%†) and favorable asymmetry (2.13×) are structurally meaningful. ARM's demonstrated FY2025 growth (+24%†) partially de-risks the base case. Buyback ROIC is verifiably structural at any NAV discount >0%. Ignoring this setup entirely would leave identified alpha on the table.
2-minute pitch
SoftBank Group holds 88% of ARM Holdings — the world's dominant chip instruction-set architecture, embedded in every smartphone and rapidly expanding into AI data-center CPUs. ARM's royalty revenue grew 24% last year and re-rates higher with each new architecture generation. Yet SFTBY (the US ADR for SBG) trades at a 35%+ discount to the value of that ARM stake alone, because the market still categorizes SBG as a venture fund — the legacy of Vision Fund 1's $30B+ in losses. Vision Fund 1 is winding down. Vision Fund 2's AI portfolio has partially recovered. No Vision Fund 3 has been announced. Meanwhile, SBG's telecom subsidiary (SoftBank Corp) generates ¥820-850B in annual EBITDA and fuels an ongoing ¥500B/year buyback that purchases ARM exposure at 35% off retail.
The investment is: buy ARM's royalty stream at a 35% discount by owning SFTBY instead of ARM directly, accept the holdco drag (leverage + governance + OTC illiquidity), and let ARM's compounding reduce the discount over time. Base-case return is +14% in 12 months with 45% probability; bear case is −36% with 25% probability; bull case is +43% with 30% probability. Expected value +10.2%, asymmetry 2.13×. Start at 1-2% position size; verify ARM revenue and SBG NAV via R2 verification before initiating; scale to 3% if ARM Q1 FY2026 earnings confirm the royalty trajectory.
When NOT to buy (K.5 anti-pattern check)
- If you already hold direct ARM (NASDAQ: ARM) at >3% portfolio weight — SFTBY adds leverage and governance risk to the same underlying exposure; do NOT double up
- If VF3 is announced before position initiation — wait for the full VF3 terms before deciding; capital allocation thesis is partially invalidated
- If ARM stock has risen >30%† from current levels without a fundamental earnings re-rating — at lower NAV discounts the asymmetry degrades; recalculate EV before adding
- If LTV has moved above 22%† in the most recent 決算短信 — the bear tail is closer than modeled; size conservatively at 0.5% pending R2
† All figures GENERATE mode (Tier C). R2 verification required before any position initiation.